ALLURION TECHNOLOGIES, INC.
ALUROTCHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $15.2M | $32.1M | $53.5M | $64.2M |
| Operating income | −$30.2M | −$50.2M | −$79.1M | −$32.0M |
| Net income | −$28.8M | −$7.2M | −$80.6M | −$37.7M |
| Total assets | $15.8M | $32.8M | $71.7M | $51.4M |
| Total liabilities | $93.0M | $110.8M | $142.2M | $83.7M |
| Equity | −$77.2M | −$78.0M | −$71.3M | −$32.3M |
| EPS (diluted) | $-3.81 | $-3.20 | $-57.83 | $-1.51 |
| Shares out. | 6.0M | 47.9M | 1.9M | 27.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −198.0%
- Net margin
- −188.8%
- Return on equity
- 37.3%
- Return on assets
- −182.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 589.4%
- Debt / equity
- —
- Book value / share
- $-12.94
- Revenue growth (YoY)
- −52.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -76.26distress
- Accruals / assets
- 1.2%clean
- Beneish M-Score
- -3.06normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 17, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Rtw Investments, LpActivist (13D)Mar 2, 2026
- Armistice Capital, LlcPassive (13G)May 15, 2025
- Leavitt Equity Partners Iii, L.P.Passive (13G)Feb 26, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 80,298 | 1.0 | -4.3% |
| Apr 30, 2026 | 83,880 | 1.8 | -19.4% |
| Apr 15, 2026 | 104,007 | 1.0 | -59.1% |
| Mar 31, 2026 | 254,092 | 1.3 | -20.9% |
| Mar 13, 2026 | 321,247 | 1.0 | -69.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Changed auditorMay 27, 2026
- Delisting / listing-standard notice · Other material eventMar 12, 2026
- Delisting / listing-standard notice · Other material eventMar 2, 2026
- Entered a material agreement · Unregistered equity sale · Modified shareholder rightsFeb 25, 2026
- Regulation FD disclosureFeb 23, 2026
- Results of operationsJan 12, 2026
- Shareholder voteDec 19, 2025
- Entered a material agreement · Results of operations · Unregistered equity sale · Other material eventNov 12, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.